SCHEMBL7871708

SCHEMBL7871708

CC1(C)CCC(C)(C)c2cc(C(=O)C(=O)O)ccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 13/20 0.66
RARB P10826 13/20 0.66
RARG P13631 12/20 0.66
RXRB P28702 9/20 0.66
RXRG P48443 6/20 0.66
RARA P10276 10/20 0.62
CYP26A1 O43174 4/20 0.60
CYP26B1 Q9NR63 1/20 0.60
CYP3A4 P08684 3/20 0.57
ALDH1A1 P00352 2/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
MEN1 O00255 1/20 0.57
CYP2C9 P11712 1/20 0.57
TSHR P16473 1/20 0.57
MAPK1 P28482 1/20 0.57
KMT2A Q03164 1/20 0.57
CRABP2 P29373 1/20 0.56
KDM4E B2RXH2 1/20 0.56
NPC1 O15118 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9319026 0.86 RXRA (0.77) RXRARARBRARGRXRBRXRG
SCHEMBL846110 0.85 RARB (0.81) RXRARARBRARGRXRBRXRG
SCHEMBL29827631 0.85 RARB (0.81) RXRARARBRARGRXRBRXRG
SCHEMBL7885961 0.84 RXRA (0.59) RXRARARBRARGRXRBRXRG
Hydrochloric Acid SCHEMBL9120757 0.84 RARB (0.78) RXRARARBRARGRXRBRXRG
SCHEMBL8733241 0.83 RARB (0.83) RXRARARBRARGRXRBRXRG
SCHEMBL5364751 0.83 RARB (0.68) RXRARARBRARGRXRBRXRG
Hydrazine SCHEMBL9430381 0.82 RARB (0.76) RXRARARBRARGRXRBRXRG
SCHEMBL2195224 0.81 RXRA (0.66) RXRARARBRARGRXRBRXRG
SCHEMBL1615120 0.81 RARB (0.56) RXRARARBRARGRXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331570-B1 PREVENTION OF SPONTANEOUS SQUAMOUS CELL CARCINOMA IN IMMUNOCOMPROMISED HUMAN TRANSPLANT PATIENTS BRISTOL-MYERS SQUIBB COMPANY 2001-12-18 US disclosed
US-6171603-B1 TREATING SKIN, HAIR, CARDIOVASCULAR, AUTOIMMUNE AND VISION DISORDERS; ADMINISTERING AS ANTICARCINOGENIC, ANTIDEPRESSANT,ANTIINFLAMMATORY, AND ANTIACNE AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2001-01-09 US disclosed
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed
US-5935585-A Biaromatic amido compounds and pharmaceutical/cosmetic compositions comprised thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-08-10 US disclosed
EP-0747347-B1 RAR-gamma-specific retinobenzoic acid derivatives BRISTOL MYERS SQUIBB CO (US) 1999-07-21 EP disclosed
US-5760084-A TREATING DERMATOLOGICAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-06-02 US disclosed
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed
US-5688817-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, IMMUNOLOGY AND RHEUMATIC DISORDERS CENTRE INT'L. DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1997-11-18 US disclosed
EP-0728739-B1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations CIRD GALDERMA (FR) 1997-11-05 EP disclosed
US-5668156-A TREATMENT OF WARTS, ACNE, PSORIASIS, CORNEOPATHIES, KETONES CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1997-09-16 US disclosed
US-5624957-A RETINOID ACTIVE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 1997-04-29 US disclosed
US-5597839-A TREATMENT OF SKIN DISORDERS OR ANTIINFLAMMATORY AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1997-01-28 US disclosed
EP-0747347-A1 RARy-specific retinobenzoic acid derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-11 EP disclosed
US-5567721-A AROMATIC UREA COMPOUND FOR SKIN DISORDER, RHEUMATIC DISEASE, RESPIRATORY DISORDER AND EYE DISORDER CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 1996-10-22 US disclosed
EP-0728739-A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-08-28 EP disclosed
US-5439925-A Skin disorders, rheumatic diseases CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-08 US disclosed
US-5387594-A Administering for topical and systemic treatment of CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-02-07 US disclosed
EP-0552282-B1 BI-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN AND VETERINARY MEDECINE AND IN COSMETIC PREPARATIONS CIRD GALDERMA (FR) 1994-08-24 EP disclosed
EP-0552282-A1 BI-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN AND VETERINARY MEDECINE AND IN COSMETIC PREPARATIONS. CIRD GALDERMA (FR) 1993-07-28 EP disclosed
WO-1992006948-A1 BI-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN AND VETERINARY MEDECINE AND IN COSMETIC PREPARATIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-04-30 WO disclosed